JOINT FILING AGREEMENT
Exhibit A
The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule
13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
Dated: November 23, 2018
|
InvaGen Pharmaceuticals Inc.
|
|||
|
By:
|
/s/ Xxxxxx Xxxxxxx
|
||
|
Name:
|
Xxxxxx Xxxxxxx
|
||
|
Title:
|
Director |
||
|
Cipla (EU) Limited
|
|||
|
By:
|
/s/ Xxxxxxxx Xxxxxxxx
|
||
|
Name:
|
Xxxxxxxx Xxxxxxxx
|
||
|
Title:
|
Director |
||
|
Cipla Limited
|
|||
|
/s/ A.S. Kumar
|
|||
|
Name:
|
A.S. Kumar
|
||
|
Title:
|
Global General Counsel and Executive Vice President
|
||
